RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
107B
SLCVX
Price
$28.97
Change
+$0.24 (+0.84%)
Updated
Jun 26 closing price
Net Assets
18.69M
Interact to see
Advertisement

RMEBX vs SLCVX

Header iconRMEBX vs SLCVX Comparison
Open Charts RMEBX vs SLCVXBanner chart's image
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets107B
Saratoga Large Capitalization Value I
Price$28.97
Change+$0.24 (+0.84%)
VolumeN/A
Net Assets18.69M
RMEBX vs SLCVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RMEBX vs. SLCVX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Buy and SLCVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 107B vs. SLCVX (18.7M). RMEBX pays higher dividends than SLCVX: RMEBX (1.16) vs SLCVX (0.00). RMEBX was incepted earlier than SLCVX: RMEBX (11 years) vs SLCVX (31 years). SLCVX (1.88) is less costly to investors than RMEBX (1.07). SLCVX is a more actively managed with annual turnover of: 83.00 vs. RMEBX (31.00). RMEBX (250) and SLCVX (250) have matching initial minimum investment requirements. RMEBX annual gain was more profitable for investors over the last year : 9.50 vs. SLCVX (0.28). RMEBX return over 5 years is better than : 62.71 vs. SLCVX (43.43).
RMEBXSLCVXRMEBX / SLCVX
Total Expense Ratio1.071.8857%
Annual Report Gross Expense Ratio1.071.8857%
Fund Existence11 years31 years-
Gain YTD7.31510.54369%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets107B18.7M572,193%
Annual Yield % from dividends1.160.00-
Returns for 1 year9.500.283,401%
Returns for 3 years25.8815.43168%
Returns for 5 years62.7143.43144%
Returns for 10 years74.5124.97298%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp